BiondVax Pharmaceuticals Ltd.
BVXV · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8 | $11 | $14 | $29 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $8 | $11 | $14 | $30 |
| Property Plant & Equip (Net) | $12 | $12 | $13 | $44 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $1 |
| Total NC Assets | $12 | $12 | $13 | $45 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $20 | $23 | $27 | $75 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $1 | $1 | $2 |
| Total Curr. Liab. | $2 | $3 | $2 | $5 |
| LT Debt | $24 | $23 | $21 | $60 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $3 | $5 | $0 |
| Total NC Liab. | $25 | $26 | $26 | $60 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $6 |
| Total Liabilities | $27 | $28 | $29 | $65 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$123 | -$119 | -$116 | -$383 |
| AOCI | -$2 | -$2 | -$2 | $0 |
| Other Equity | $118 | $116 | $116 | $393 |
| Total Equity | -$7 | -$5 | -$2 | $9 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $20 | $23 | $27 | $75 |
| Net Debt | $17 | $12 | $7 | $33 |